Compound ID | 463
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Folate synthesis inhibitor. Dihydrofolate reductase inhibitor |
| Target Pathogen: | Active against Streptococcus pneumoniae; active against pathogens causing upper and lower respiratory tract infections |
| Propensity to select resistant mutants: | Yes (1E-10) |
| Description: | Diaminopyrimidine antibiotic; Mukhija S, Rigo S, Parisi S, et al. AR-709 - an investigational diaminopyrimidine: inhibition, binding and mode of action. 46th-Intersci-Conf-Antimicrobial-Agents-Chemother 2006;227 |
| Institute where first reported: | Arpida (Evolva Holding SA, Switzerland) |
| Year first mentioned: | 2006 |
| Highest development stage: | Phase 1 |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/11226413 |
| Citation: | https://doi.org/10.1128/aac.01332-07 |